| |
| |
|
| Insider
Information: |
Kulkarni Samarth |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
208,122 |
|
|
Indirect Shares
|
200,000 |
|
|
| Direct
Value |
$13,228,234 |
|
|
|
Indirect Value
|
$12,712,000 |
|
|
| Total
Shares |
408,122 |
|
|
| Total
Value |
$25,940,234 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -45.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
|
2024-04-15 |
208,122 |
2024-04-15 |
200,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
113 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
Chief Business OfficerOfficer |
• – – |
2016-10-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
134,047 |
|
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,833 |
194,024 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
80,000 |
299,153 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,834 |
290,919 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
294,432 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2022-12-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
330,279 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,250 |
382,361 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,833 |
387,821 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2023-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
391,463 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,250 |
200,627 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,250 |
213,507 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2024-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
212,705 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-19 |
4 |
OE |
$1.81 |
$13,137 |
D/D |
7,258 |
141,305 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-20 |
4 |
OE |
$1.81 |
$5,068 |
D/D |
2,800 |
136,847 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-21 |
4 |
OE |
$1.81 |
$5,430 |
D/D |
3,000 |
137,047 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-24 |
4 |
OE |
$1.81 |
$6,335 |
D/D |
3,500 |
137,547 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-25 |
4 |
OE |
$1.81 |
$9,258 |
D/D |
5,115 |
139,162 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-26 |
4 |
OE |
$1.81 |
$5,928 |
D/D |
3,275 |
137,322 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-27 |
4 |
OE |
$1.81 |
$3,993 |
D/D |
2,206 |
136,253 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• – – |
2017-12-21 |
4 |
OE |
$1.81 |
$27,150 |
D/D |
15,000 |
148,560 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-06-01 |
4 |
OE |
$1.81 |
$27,150 |
D/D |
15,000 |
163,560 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-12-07 |
4 |
OE |
$1.81 |
$38,915 |
D/D |
21,500 |
167,290 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-04-29 |
4 |
OE |
$1.81 |
$36,200 |
D/D |
20,000 |
186,542 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-06-17 |
4 |
OE |
$1.81 |
$36,200 |
D/D |
20,000 |
185,801 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-12-16 |
4 |
OE |
$1.81 |
$14,480 |
D/D |
8,000 |
172,320 |
0 |
- |
|
113 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
